Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

ClinicalTrials.gov ID: NCT00673075

Public ClinicalTrials.gov record NCT00673075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension

Study identification

NCT ID
NCT00673075
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Forest Laboratories
Industry
Enrollment
39 participants

Conditions and interventions

Interventions

  • Nebivolol Drug
  • Carvedilol Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Aug 31, 2009
Completion
Not listed
Last update posted
Sep 27, 2010

Started 2008

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Forest Investigative Site Birmingham Alabama 35294
Forest Investigative Site Peoria Arizona 85381
Forest Investigative Site Buena Park California 90620
Forest Investigative Site Los Angeles California 90048
Forest Investigative Site Orange California 92868
Forest Investigator Site Santa Ana California 92705
Forest Investigative Site Guilford Connecticut 06437
Forest Investigator Site Coral Gables Florida 33134
Forest Investigative Site Daytona Beach Florida 32117
Forest Investigator Site Hollywood Florida 33021
Forest Investigator Site New Smyrna Beach Florida 32168
Forest Investigative Site Orlando Florida 32803
Forest Investigator Site Winter Haven Florida 33880
Forest Investigative Site Chicago Illinois 60611
Forest Investigator Site Indianapolis Indiana 46254
Forest Investigator Site Lafayette Louisiana 70503
Forest Investigator Site Auburn Maine 04210
Forest Investigative Site Pittsfield Massachusetts 01201
Forest Investigator Site Worcester Massachusetts 01655
Forest Investigative Site Detroit Michigan 48202
Forest Investigative Site Lansing Michigan 48910
Forest Investigator Site Las Vegas Nevada 89119
Forest Investigative Site Northport New York 11768
Forest Investigative Site The Bronx New York 10451
Forest Investigative Site The Bronx New York 10468
Forest Investigative Site Charlotte North Carolina 28211
Forest Investigator Site Lenoir North Carolina 28645
Forest Investigative Site Fargo North Dakota 58103
Forest Investigative Site Cincinnati Ohio 45219
Forest Investigative Site Lancaster Pennsylvania 17603
Forest Investigative Site Charleston South Carolina 29401
Forest Investigator Site Florence South Carolina 29501
Forest Investigative Site Cleveland Tennessee 37312
Forest Investigative Site Carrollton Texas 75006

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00673075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2010 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00673075 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →